Aspirin submission
This article was originally published in The Tan Sheet
Executive Summary
Aspirin "appears to be a significant player in the reduction in the incidence of CHD events and non-fatal myocardial infarction," according to a recent submission to FDA. Al Bartolucci, PhD, University of Alabama, et al., conducted a meta-analysis of the six major clinical trials on use of aspirin for primary prevention of heart attack, including the Women's Health Study. The researchers used data provided by the U.S. Preventive Services Task Force, finding that aspirin reduces incidence of cardiovascular events defined as a composite of CV deaths, MI and stroke. The drug had "no significant effect on stroke, fatal CHD or all-cause mortality," Bartolucci et al. add. The submission references Bayer's citizen petition submitted in 2003 seeking an indication on aspirin professional labeling for primary prevention of MI. Bartolucci et al. say their analysis is shorter version of a full-length manuscript they will submit to FDA in the future...
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.